Novartis is buying gene therapy and neuroscience biotech Kate Therapeutics in a deal worth $1.1 billion in upfront and milestone payments, the Swiss pharma confirmed …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Good morning, I’m back! And I can barely believe all the news that happened while I was away. On vacation, my biggest concern was a
In its latest push into the field of targeted protein degradation, Astellas has tapped fellow Japanese company PeptiDream for a research collaboration and licensing deal.
Montana lawmakers are in a standoff with the state’s health department over a package of sweeping changes to child care licensing rules that includes a